Medicine and Health Sciences Commons^™

Suicide From A Global Perspective, Amresh Srivastava

Amresh Srivastava

This book is in 5 volumes, Hard cover and e-book, with 110 Chapters and contributions from more than 30 Countries

Amresh Shrivastava (ed), Megan Kimbrell and David Lester Handbook of Suicide From Global Perspective

Preface by Professor N. Sartorius, MD, PhD

Suicide is the cause of death for nearly one million people a year. Death by suicide is often reported as being due to other causes to avoid stigmatization and other negative consequences of suicide for the family: it can therefore be assumed that the number of people who commit suicide is much higher than this number. Attempts of suicide …

Beyond Early Intervention, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Serum Lipids And Suicidality In Early Psychosis: Is There A Connection? A Preliminary Study, Amresh Srivastava, Megan Johnston, Lenore Purde, Robbie Campbell

Amresh Srivastava

No abstract provided.

Psychoendocrinology (Thyroid Hormone) And Early Psychosis: Preliminary Findings, Amresh Srivastava, Megan Johnston, Lenore Purde, Robbie Campbell

Amresh Srivastava

No abstract provided.

Enhancing Risk Assessment Across Mental Health Services, Amresh Srivastava, Megan Johnston, Charles Nelson

Amresh Srivastava

No abstract provided.

Weight-Gain In Psychiatric Treatment: Risks, Implications, And Strategies For Prevention And Management, Amresh Srivastava, Megan Johnston

Amresh Srivastava

Weight-gain in psychiatric populations is a common clinical challenge. Many patients suffering from mental disorders, when exposed to psychotropic medications, gain significant weight with or without other side-effects. In addition to reducing the patients' willingness to comply with treatment, this weight-gain may create added psychological or physiological problems that need to be addressed. Thus, it is critical that clinicians take precautions to monitor and control weight-gain and take into account and treat all problems facing an individual. In this review, we examine some of the key issues surrounding weight-gain in individuals suffering from mental disorders for contemporary practitioners in community …

Current Understanding And Pharmacological Management Of Suicide Behavior In Clinical Setting, Amresh Shrivastava

Amresh Srivastava

This presentation addresses these issues:
• Nature of problem in clinical settings
• Current understanding about suicide behavior (neurobiology)
• What can be done to deal with suicide in clinical settings
• Pharmacological management

Is The Risk Syndrome For Psychosis Risky Business?, Amresh Shrivastava

Amresh Srivastava

No abstract provided.

Treatment Resistant Depression, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Switching And Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Social Determinants Of Health And Disease Working Together, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Outcome In Schizophrenia: The Long-Term Good Outcome In Schizophrenia Is Not Yet Good Enough, Amresh Srivastava, Meghan Thakar

Amresh Srivastava

The illness of schizophrenia has always been a matter of concern for its nature and extent of outcome particularly for its regional and cultural differences. The concept of outcome has been evolving and this study examines the scenario of good outcome in developing countries.

Brain, Mind And Behaviour - Emerging Biological Connections, Amresh Srivastava

Amresh Srivastava

No abstract provided.

Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts A Positive Clinical And Social Outcome At Five Years, Post Discharge Follow-Up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, Nilesh Shah

Amresh Srivastava

Serum prolactinis an indicator of tuberoinfundibulardopamine activity. It is reported to increase in wide variety of mental illnesses. It has close relationship with antipsychotic therapy. However, its relationship with psychopathology and outcome is not clear. Serum prolactinlevel was measured in 30 male and 30 female drug naive patients of schizophrenia. Subsequently, these patients were treated with antipsychotics. The severity of psychopathology at the baseline and subsequent improvement at the end of 3 weeks and 6 weeks was assessed on modified brief psychiatric rating scale (mBPRS). Available to follow up at five years 18 males & 22 females patients were reassessed …

Perspectives In Social Outcome Of Schizophrenia, Amresh Shrivastava

Amresh Srivastava

No abstract provided.

Prescribing Practices Of Clozapine In India: Results Of A Opinion Survey Of Psychiatrists, Amresh Shrivastava, Nilesh Shah

Amresh Srivastava

No abstract provided.

Should Antipsychotics Be Used In Prodromal Phase Of Psychosis?, Amresh Shrivastava

Amresh Srivastava

No abstract provided.

Early Psychosis: A Bridge To Future, Amresh Srivastava

Amresh Srivastava

No abstract provided.